Anebulo Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$5.68 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$1.77 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
AnaptysBio, Inc. |
$16.88 | $640.07 M | -3.82 | 117 | $17.16 M |
ANTX
AN2 Therapeutics, Inc. |
$1.27 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.54 | $597.48 M | -6.84 | 51 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$9.80 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.30 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
Opthea Limited |
$4.41 | $214.34 M | -1.04 | 33 | $124,666 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.35 | $85.40 M | -1.26 | 63 | $0 |